Greenberg Traurig shareholder Flora Perez helped structure an acquisition on behalf of a wireless medical technology company in a deal that required navigating complex Swiss regulations.

Perez led the legal team representing BioTelemetry Inc., a publicly traded company based in Pennsylvania, in its $280 million purchase of Switzerland's LifeWatch AG, a health care technology company.

BioTelemetry, formerly known as CardioNet Inc., provides cardiac monitoring services, centralized lab services and original equipment manufacturing with a primary focus on cardiac monitoring devices. While both companies operate in the U.S., most of LifeWatch's shareholders reside outside national borders.